Right under your nose: A more convenient way to diagnose Alzheimer's disease

by Daegu Gyeongbuk Institute of Science and TechnologyCredit: CC0 Public DomainScientists from the Daegu Gyeongbuk Institute of Science and Technology, Republic of Korea, have discovered a new way to

Updated on: July 04,2024

Right under your nose: A more convenient way to diagnose Alzheimer's disease

by Daegu Gyeongbuk Institute of Science and TechnologyCredit: CC0 Public DomainScientists from the Daegu Gyeongbuk Institute of Science and Technology, Republic of Korea, have discovered a new way to

Updated on:July 04,2024

Brain activity associated with specific words is mirrored between speaker and listener during a conversation, data show

byCell PressCoupling between speaker and listener brains. Credit:Neuron/ Zada et al.When two people interact, their brain activity becomes synchronized, but it was unclear until now

Updated on: August 08,2024

Brain activity associated with specific words is mirrored between speaker and listener during a conversation, data show

byCell PressCoupling between speaker and listener brains. Credit:Neuron/ Zada et al.When two people interact, their brain activity becomes synchronized, but it was unclear until now

Updated on:August 08,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on: March 07,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on:March 07,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on: April 16,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on:April 16,2024

Potassium-enriched salt shows promise for cutting recurrent stroke risk in clinical trial

Updated on: April 09,2025

Potassium-enriched salt shows promise for cutting recurrent stroke risk in clinical trial

Updated on:April 09,2025

New figures show dementia is leading cause of death in England and Wales

by Alzheimer's Research UKNew figures released by the Office of National Statistics show that for the first time, Alzheimer's disease and other dementias are the leading cause of death fo

Updated on: March 07,2024

New figures show dementia is leading cause of death in England and Wales

by Alzheimer's Research UKNew figures released by the Office of National Statistics show that for the first time, Alzheimer's disease and other dementias are the leading cause of death fo

Updated on:March 07,2024

Study finds spinal manipulative therapy benefits patients with tension-type headaches

byUniversity Hospitals Cleveland Medical CenterCredit: Pixabay/CC0 Public DomainA team of researchers led by University Hospitals Connor Whole Health have identified an association between spina

Updated on: December 22,2024

Study finds spinal manipulative therapy benefits patients with tension-type headaches

byUniversity Hospitals Cleveland Medical CenterCredit: Pixabay/CC0 Public DomainA team of researchers led by University Hospitals Connor Whole Health have identified an association between spina

Updated on:December 22,2024

Old drug offers new hope to treat Alzheimer's disease

by Gladstone InstitutesVarious pills. Credit: WikipediaScientists from the Gladstone Institutes have discovered that salsalate, a drug used to treat rheumatoid arthritis, effectively reversed tau

Updated on: February 26,2024

Old drug offers new hope to treat Alzheimer's disease

by Gladstone InstitutesVarious pills. Credit: WikipediaScientists from the Gladstone Institutes have discovered that salsalate, a drug used to treat rheumatoid arthritis, effectively reversed tau

Updated on:February 26,2024

Is dementia on the decline? Research suggests it might be

by Allie Shah, Star Tribune (Minneapolis)Despite fears that the coming silver tsunami will trigger a dementia epidemic, a surprising new study suggests that it may be possible to delay - or even preve

Updated on: February 28,2024

Is dementia on the decline? Research suggests it might be

by Allie Shah, Star Tribune (Minneapolis)Despite fears that the coming silver tsunami will trigger a dementia epidemic, a surprising new study suggests that it may be possible to delay - or even preve

Updated on:February 28,2024

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Updated on: February 28,2024

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Updated on:February 28,2024

New brain discovery could help in the fight against obesity

byUniversity of AberdeenCredit:Current Biology(2024). DOI: 10.1016/j.cub.2024.02.074One of the largest threats to human health is obesity, but now researchers from the University of

Updated on: March 28,2024

New brain discovery could help in the fight against obesity

byUniversity of AberdeenCredit:Current Biology(2024). DOI: 10.1016/j.cub.2024.02.074One of the largest threats to human health is obesity, but now researchers from the University of

Updated on:March 28,2024

Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis

byKing's College LondonGraphical Abstract. Credit:Brain Communications(2024). DOI: 10.1093/braincomms/fcae291Reduced brain activity responding to unpredicted visual changes is a

Updated on: October 16,2024

Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis

byKing's College LondonGraphical Abstract. Credit:Brain Communications(2024). DOI: 10.1093/braincomms/fcae291Reduced brain activity responding to unpredicted visual changes is a

Updated on:October 16,2024